Lonza has agreed to acquire five US contract development and [...]

Laverock Therapeutics is expanding its therapeutic pipeline into in vivo [...]

AstraZeneca’s Trixeo has been approved in the EU as a [...]

Novadip Biosciences has secured €10.4 million in convertible financing to [...]

Andelyn Biosciences is manufacturing Ultragenyx’s newly FDA-approved Fayuvi gene therapy [...]

Oncodesign Services and Nexus BioQuest have formed a preclinical research [...]

A US National Institutes of Health grant will fund an [...]

Resolution Therapeutics has partnered with Blood Centers of America to [...]

Resolution Therapeutics has treated the final patient in its Phase [...]

Eleva is separating its moss-based biologics platform from its clinical-stage [...]